Reference Interval:
By Report
|
| Interpretive Data: |
Background Information for Galactosemia (GALT), Sequencing:
Characteristics: Vomiting, diarrhea, feeding problems, failure to thrive, hepatocellular damage, bleeding, sepsis, mental retardation, and neonatal death. If treated early, most symptoms resolve, although speech, motor problems, developmental delay and premature ovarian failure may persist.
Incidence: Approximately 1 in 30,000.
Inheritance: Autosomal recessive
Penetrance: 100 percent for severe mutations.
Cause: Pathogenic galactose-1-phosphate uridyl transferase (GALT) gene mutations.
Clinical sensitivity: 98 percent.
Methodology: Bidirectional sequencing of the entire GALT coding region, intron/exon boundaries and partial 5'UTR.
Analytic Sensitivity & Specificity: 99 percent.
Limitations: Rare diagnostic errors can occur due to primer site mutations. Regulatory region mutations, deep intronic mutations, and large deletions/duplications will not be detected. Mutations in genes other than GALT are not evaluated.
Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.
See Compliance Statement C: www.aruplab.com/CS
|
| CPT Code(s): |
81406
|
|
![[ image for: Patient History For Galactosemia]](icon_19.jpg){kind=icon}
![[ image for: Additional Technical Information]](icon_364.jpg){kind=icon}